IP Library › Granted Patent US 10,760,084
Granted Patent B2
US 10,760,084 · App. 15/775,797 · Granted Sep 1, 2020

α-amylase-binding nucleic acid molecule and use thereof

Inventors: Hirotaka Minagawa (Tokyo, JP); Katsunori Horii (Tokyo, JP); Jou Akitomi (Tokyo, JP); Naoto Kaneko (Tokyo, JP); Ikuo Shiratori (Tokyo, JP); Iwao Waga (Tokyo, JP); Masayasu Kuwahara (Gunma, JP)
Assignees: NEC Solution Innovators, Ltd.; Gunma University
C12N15/115C12Q1/40C12Q1/68G01N33/53C12N15/1048C12N2310/16C12N2310/335C12Y302/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,760,084
App. No.
15/775,797
Granted
Sep 1, 2020
Kind
B2
Abstract

The present invention provides a novel nucleic acid molecule that can be used for detection of α-amylase. The α-amylase-binding nucleic acid molecule of the present invention is characterized in that it binds to α-amylase with a dissociation constant of 17 nM or less, and preferably includes a polynucleotide consisting of any of base sequences of SEQ ID NOs: 1 to 22, for example. According to the nucleic acid molecule of the present invention, it is possible to detect α-amylase in saliva.

Claims (27)

1. An α-amylase-binding nucleic acid molecule comprising the following polynucleotide (a) or (c):

(a) a polynucleotide consisting of any of base sequences of SEQ ID NOs: 1 to 22; and

(c) a polynucleotide that consists of a base sequence having at least 80% sequence identity to any of the base sequences of the polynucleotide (a) and binds to the α-amylase.

2. The α-amylase-binding nucleic acid molecule according to claim 1 , wherein

the α-amylase-binding nucleic acid molecule comprises a modified base, which is a base modified with a modifying group.

3. The α-amylase-binding nucleic acid molecule according to claim 2 , wherein

the modified base is a modified thymine.

4. The α-amylase-binding nucleic acid molecule according to claim 2 , wherein

the modifying group is an adenine residue or a substituted adenine residue.

5. The α-amylase-binding nucleic acid molecule according to claim 4 , wherein

the substituted adenine residue has a substituent bound to N at a 9-position.

6. The α-amylase-binding nucleic acid molecule according to claim 5 , wherein

the substituent is an amidino aminoalkyl group.

7. The α-amylase-binding nucleic acid molecule according to claim 6 , wherein

the amidino aminoalkyl group is a 4-amidino aminobutyl group.

8. The α-amylase-binding nucleic acid molecule according to claim 2 , wherein

the modified base is a modified purine base with a 7-position of a purine base being modified with the modifying group or a modified pyrimidine base with a 5-position of a pyrimidine base being modified with the modifying group.

9. The α-amylase-binding nucleic acid molecule according to claim 2 , wherein

the polynucleotide is a DNA.

10. An α-amylase analysis sensor comprising:

the α-amylase-binding nucleic acid molecule according to claim 1 .

11. An α-amylase analysis method comprising the step of:

detecting α-amylase in a specimen by causing the specimen and a nucleic acid molecule to come into contact with each other,

wherein the nucleic acid molecule is the α-amylase-binding nucleic acid molecule according to claim 1 , and

in the detection step, the nucleic acid molecule is caused to bind to the α-amylase in the specimen, and the α-amylase in the specimen is detected by detecting the binding.

12. The α-amylase analysis method according to claim 11 , wherein

the specimen is at least one selected from the group consisting of saliva, urine, plasma, and serum.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2018
From: MINAGAWA, HIROTAKA; HORII, KATSUNORI; AKITOMI, JOU; KANEKO, NAOTO; SHIRATORI, IKUO; WAGA, IWAO; KUWAHARA, MASAYASU
To: NEC SOLUTION INNOVATORS, LTD.; GUNMA UNIVERSITY
Reel/Frame 045785/0710 →
Priority Claims (1)
JP 2015-222952 · Nov 13, 2015 · national
Continuity (1)
Related Publication 20180327746A1 · Nov 15, 2018